Molecular Templates, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Posters
    • Articles
  • Pipeline
    • Overview
    • MT-5111
    • MT-0169
    • MT-6402
  • Clinical Trials
    • Overview
    • Expanded Access
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Email Alerts
  • Contact
  • Careers

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events

Molecular Templates’ Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2020 Highlight Evolution of ETB Platform

Jun 22, 2020 7:30am EDT

Molecular Templates, Inc. Announces $45 Million Debt Financing From K2 HealthVentures

May 22, 2020 8:00am EDT

New Data on Molecular Templates’ Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Virtual Annual Meeting II

May 15, 2020 7:00am EDT

Molecular Templates to Participate in Two May Virtual Investor Conferences

May 13, 2020 4:30pm EDT

Molecular Templates, Inc. Reports First Quarter 2020 Financial Results

May 11, 2020 4:30pm EDT

Molecular Templates, Inc. Announces that the 2020 Annual Meeting of Stockholders Will be Held in Virtual Format

May 07, 2020 4:30pm EDT

Molecular Templates, Inc. Reports Fourth Quarter 2019 Financial Results

Mar 12, 2020 4:30pm EDT

Molecular Templates to Present at Three March Investor Conferences

Feb 28, 2020 8:00am EST

Molecular Templates, Inc. Announces Dosing of First Subject in Phase I Study of TAK-169 in Relapsed/Refractory Multiple Myeloma

Feb 19, 2020 7:00am EST

Molecular Templates Provides Corporate Update and Outlines 2020 Milestones

Jan 08, 2020 8:00am EST
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...11
    Next
    © 2022 Molecular Templates, Inc. All Rights Reserved.
    Twitter Linkedin
    Privacy Policy Disclaimer Terms of Use Sitemap Expanded Access